Vaxart, Inc. Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31)
Vaxart, Inc. (VXRT) reported Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) of $3.00 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2012-03-14.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease · last filed 2012-03-14
- Vaxart, Inc. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for fiscal 2011 was $3.00K, a 82.35% decline from fiscal 2010.
- Vaxart, Inc. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for fiscal 2010 was $17.00K.
- Vaxart, Inc. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for fiscal 2009 was -$80.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 12 month |
|---|---|
| 2011-12-31 | $3.00K 10-K · filed 2012-03-14 |
| 2010-12-25 | $17.00K 10-K · filed 2012-03-14 |
| 2009-12-26 | -$80.00K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |